GALAPAGOS
GALAPAGOS NV, commonly referred to as Galapagos, is a pioneering biotechnology company headquartered in the United States, with significant operations in Europe. Founded in 1999, Galapagos has established itself in the pharmaceutical industry, focusing on the discovery and development of innovative medicines for various diseases, including inflammatory and fibrotic conditions. The company is renowned for its unique drug discovery platform, which leverages advanced technologies to identify and develop novel therapeutic candidates. Notable achievements include the successful development of several clinical-stage programmes, positioning Galapagos as a leader in the biopharmaceutical sector. With a commitment to scientific excellence and a robust pipeline, Galapagos continues to make significant strides in transforming patient care through groundbreaking therapies.
DitchCarbon Score
How does GALAPAGOS's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
GALAPAGOS's score of 25 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
GALAPAGOS's reported carbon emissions
As of the latest available data, GALAPAGOS has not reported any specific carbon emissions figures, indicating a lack of publicly disclosed emissions data. Consequently, there are no absolute emissions numbers to analyse, including Scope 1, 2, or 3 emissions. In terms of climate commitments, GALAPAGOS has not established any documented reduction targets or initiatives, nor have they made any climate pledges. This absence of data suggests that the organisation may still be in the early stages of developing a comprehensive climate strategy. It is important to note that emissions data is not cascaded from any parent or related organisation, and GALAPAGOS operates independently in this regard. As the company progresses, it may consider adopting industry-standard climate initiatives and setting measurable targets to enhance its sustainability profile.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
GALAPAGOS is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
